Switch to a Completely ONce Daily Regimen Containing Emtricitabine/Tenofovir – Fixed Dose Combination Plus Third QD Partner: 'SONETT'
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2008
At a glance
- Drugs Antiretrovirals; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SONETT
- Sponsors Gilead Sciences
- 06 Jun 2008 Status changed from in progress to completed.
- 14 Nov 2006 New trial record.